V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300005949 | 300007683 | 1.54 | 48.5 | Curative (C) | 2013-06-21 | 2013-06-24 | Carboplatin AUC 6 - 10 | 1 | Y | 300008606 | FLUOROURACIL |
| 300005950 | 300004072 | 1.53 | null | null | 2015-06-19 | 2015-07-08 | Cetuximab 7 day (>Cycle 2) | null | Y | 300008620 | CAPECITABINE + RT |
| 300005951 | 300004075 | 1.64 | 96 | Neo-adjuvant (N) | 2016-05-31 | 2016-06-27 | CAPECITABINE + OXALIPLATIN | N | N | 300008623 | TRIAL |
| 300005952 | 300004076 | 1.67 | 71.4 | Not known (9) | 2017-06-20 | 2017-06-20 | Cisplatin + Docetaxel | 02 | null | 300008635 | VAI |
| 300005953 | 300004077 | 1.52 | 56.8 | Adjuvant (A) | 2016-04-01 | 2016-04-01 | CISPLATIN + ETOPOSIDE | N | Y | 300008640 | TRIAL |
| 300005954 | 300006662 | 1.67 | 60.9 | Adjuvant (A) | 2017-07-21 | 2017-07-29 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 300008641 | CAPECITABINE + OXALIPLATIN |
| 300005955 | 300004078 | 1.67 | 48 | Curative (C) | 2017-02-19 | 2017-02-25 | Cetuximab 7 day (>Cycle 2) | N | Y | 300008645 | CARBOPLATIN + RT |
| 300005956 | 300004078 | null | 94 | Palliative (P) | 2015-04-09 | 2015-05-01 | Oxaliplatin + Modified de Gramont | N | N | 300008645 | NIVOLUMAB |
| 300005957 | 300004079 | 1.63 | 73.9 | Adjuvant (A) | 2013-01-04 | 2013-05-13 | Carbo F | 2 | N | 300008678 | CAPECITABINE + OXALIPLATIN |
| 300005958 | 300004079 | 1.74 | null | null | 2017-12-13 | 2017-12-20 | Cetuximab + Radiotherapy Maint | N | Y | 300008678 | CARBOPLATIN + RT |
| 300005959 | 300004080 | 1.49 | 59.9 | Palliative (P) | 2015-05-24 | 2015-06-07 | Carboplatin AUC 6 - 10 | N | Y | 300008683 | CISPLATIN |
| 300005960 | 300006665 | 1.6 | 77.9 | Palliative (P) | null | 2018-02-17 | Hydroxycarbamide | N | N | 300008687 | CETUXIMAB |
| 300005961 | 300004081 | 1.71 | 81.4 | Adjuvant (A) | 2017-12-22 | 2018-01-15 | Irinotecan + Modified De Gramont | 02 | N | 300008708 | EOX |
| 300005962 | 300007685 | null | null | Curative (C) | 2019-04-27 | 2019-05-05 | CARBOPLATIN + FLUOROURACIL | N | null | 300008712 | CAV |
| 300005963 | 300004084 | 1.55 | null | Curative (C) | null | 2015-12-02 | Folfirinox | Y | N | 300008724 | CISPLATIN + FLUOROURACIL |
| 300005964 | 300006668 | 1.76 | null | Curative (C) | 2017-11-30 | 2018-01-04 | FLUOROURACIL + RT | N | Y | 300008740 | CISPLATIN |
| 300005965 | 300006668 | 1.64 | 58.9 | Palliative (P) | 2018-05-23 | 2018-05-31 | FEC 100 | null | null | 300008740 | CARBOPLATIN |
| 300005966 | 300008082 | 1.63 | 84.7 | Curative (C) | 2013-11-19 | 2013-11-21 | CARBOPLATIN + RT | N | Y | 300008753 | CETUXIMAB + RT |
| 300005967 | 300008082 | 0 | 93 | Curative (C) | 2016-01-07 | 2016-01-07 | CARBOPLATIN + RT | 02 | Y | 300008753 | CETUXIMAB + RT |
| 300005968 | 300004086 | 1.63 | 77.4 | Curative (C) | null | 2016-05-15 | Capecitabine | N | N | 300008757 | TRIAL |
| 300005969 | 300004086 | 1.73 | 90.6 | Palliative (P) | 2015-08-16 | 2015-09-15 | Trial Unspecified | N | N | 300008757 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300005970 | 300007688 | 1.67 | 129 | Curative (C) | 2017-04-08 | 2017-04-12 | Cetuximab + Radiotherapy Maint | N | Y | 300008772 | CETUXIMAB |
| 300005971 | 300007688 | 1.6 | 48 | Palliative (P) | 2017-12-31 | 2018-01-05 | Irinotecan + Modified De Gramont | 2 | N | 300008772 | CAPECITABINE + OXALIPLATIN |
| 300005972 | 300004089 | 1.75 | 51.5 | Curative (C) | 2014-06-10 | 2014-07-15 | Carboplatin AUC 2 - 5 | N | Y | 300008796 | CISPLATIN |
| 300005973 | 300004090 | 1.73 | 65.7 | Palliative (P) | 2017-03-19 | 2017-03-22 | Gemcitabine + Capecitabine | 2 | N | 300008807 | CAPECITABINE + GEMCITABINE |
| 300005974 | 300004091 | 1.46 | 42.4 | Curative (C) | 2017-05-14 | 2017-08-08 | Oxaliplatin + Modified de Gramont | N | N | 300008825 | CARBOPLATIN |
| 300005975 | 300004092 | null | 66.35 | Palliative (P) | 2019-01-16 | 2019-01-31 | FLUOROURACIL | 02 | N | 300008826 | NIVOLUMAB |
| 300005976 | 300004092 | 1.76 | 75.8 | Palliative (P) | 2014-12-22 | 2014-12-26 | Trial Unspecified | 02 | N | 300008826 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |
| 300005977 | 300008084 | 1.67 | 83.1 | Curative (C) | 2015-10-03 | 2015-10-03 | DE-ESCALATE TRIAL | 2 | null | 300008840 | CETUXIMAB + RT |
| 300005978 | 300004093 | null | 58.8 | Adjuvant (A) | 2015-11-22 | 2015-12-13 | Cetuximab + Radiotherapy Maint | N | Y | 300008849 | CETUXIMAB + RT |
| 300005979 | 300004093 | 1.66 | 72.6 | Not known (9) | 2016-12-26 | 2017-01-21 | LUX TRIAL | null | null | 300008849 | CARBOPLATIN |
| 300005980 | 300004094 | 1.6 | 82.5 | Curative (C) | null | 2016-05-10 | CARBOPLATIN + RT | N | Y | 300008864 | CETUXIMAB + RT |
| 300005981 | 300004094 | 1.81 | null | Palliative (P) | 2014-02-06 | 2014-02-11 | Cisplatin | 02 | N | 300008864 | CAPECITABINE |
| 300005982 | 300004095 | 1.6 | 136 | Curative (C) | 2017-02-16 | 2017-02-16 | Carboplatin AUC 2 - 5 | N | Y | 300008873 | CARBOPLATIN |
| 300005983 | 300004095 | 1.51 | 66.7 | Curative (C) | 2017-09-09 | 2017-09-27 | GemCarbo Days 1+8 | N | N | 300008873 | CARBOPLATIN + ETOPOSIDE |
| 300005984 | 300004095 | 1.81 | 70.4 | Adjuvant (A) | null | 2015-05-13 | Paclitaxel 7 day | N | N | 300008873 | CAPECITABINE + GEMCITABINE |
| 300005987 | 300004099 | 1.45 | 101.7 | Curative (C) | 2014-02-15 | 2014-04-06 | CISPLATIN + FLUOROURACIL | Y | null | 300008919 | CETUXIMAB |
| 300005988 | 300004100 | null | 85.4 | Curative (C) | 2017-11-24 | 2017-11-25 | Cetuximab 7 day (>Cycle 2) | Y | Y | 300008920 | CISPLATIN |
| 300005989 | 300006678 | null | 49.7 | Palliative (P) | 2017-10-08 | 2017-10-27 | Folfirinox | 02 | N | 300008921 | NIVOLUMAB |
| 300005990 | 300004101 | null | null | Adjuvant (A) | 2015-07-06 | 2015-07-13 | Carboplatin AUC 2 - 5 | N | N | 300008921 | BCG |
| 300005991 | 300004102 | 1.58 | 40 | Adjuvant (A) | 2015-04-07 | 2015-05-03 | CARBOPLATIN + RT | 02 | Y | 300008924 | CISPLATIN + FLUOROURACIL |
| 300005992 | 300007691 | 1.87 | null | Palliative (P) | 2015-11-03 | 2015-11-03 | CARBOPLATIN | null | null | 300008927 | KESTREL TRIAL |
| 300005993 | 300004103 | 1.61 | null | Palliative (P) | 2016-10-10 | 2016-10-16 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300008935 | CYCLOPHOSPHAMIDE + DOCETAXEL |
| 300005994 | 300004103 | 1.52 | null | Palliative (P) | 2018-02-01 | 2018-03-02 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | N | N | 300008935 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300005995 | 300004104 | 1.67 | 54.3 | null | 2014-10-10 | 2014-11-14 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | null | 300008957 | CARBOPLATIN |
| 300005996 | 300004104 | 1.62 | 65.7 | Neo-adjuvant (N) | null | 2017-12-16 | CHLVPP | N | N | 300008957 | CISPLATIN + FLUOROURACIL + RT |
| 300005997 | 300004105 | 1.77 | 46.5 | Curative (C) | null | 2018-05-08 | Melphalan IV High dose | 02 | N | 300008967 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300005998 | 300004106 | null | 98.8 | Curative (C) | null | 2015-03-21 | Capecitabine | N | N | 300008970 | CISPLATIN |
| 300005999 | 300004106 | 0 | null | Curative (C) | 2013-12-13 | 2013-12-29 | CAPECITABINE + OXALIPLATIN | N | N | 300008970 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB |
| 300006000 | 300004107 | 1.46 | 76.3 | null | 2017-09-16 | 2017-09-28 | Cetuximab + Radiotherapy Maint | N | Y | 300008979 | CETUXIMAB + RT |